Mourits MJ - Search Results

1

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.

Mourits MJ, Böckermann I, de Vries EG, van der Zee AG, ten Hoor KA, van der Graaf WT, Sluiter WJ, Willemse PH. Mourits MJ, et al. Br J Cancer. 2002 May 20;86(10):1546-50. doi: 10.1038/sj.bjc.6600294. Br J Cancer. 2002. PMID: 12085202 Free PMC article.

2

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.

Mourits MJ, Hollema H, De Vries EG, Ten Hoor KA, Willemse PH, Van Der Zee AG. Mourits MJ, et al. Hum Pathol. 2002 Mar;33(3):341-6. doi: 10.1053/hupa.2002.32226. Hum Pathol. 2002. PMID: 11979376

3

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H. Mourits MJ, et al. J Clin Pathol. 2002 Jul;55(7):514-9. doi: 10.1136/jcp.55.7.514. J Clin Pathol. 2002. PMID: 12101196 Free PMC article.

4

Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.

Mourits MJ, Van der Zee AG, Willemse PH, Ten Hoor KA, Hollema H, De Vries EG. Mourits MJ, et al. Gynecol Oncol. 1999 Apr;73(1):21-6. doi: 10.1006/gyno.1998.5316. Gynecol Oncol. 1999. PMID: 10094875

5

Ovarian cysts in women receiving tamoxifen for breast cancer.

Mourits MJ, de Vries EG, Willemse PH, ten Hoor KA, Hollema H, Sluiter WJ, de Bruijn HW, van der Zee AG. Mourits MJ, et al. Br J Cancer. 1999 Apr;79(11-12):1761-4. doi: 10.1038/sj.bjc.6690280. Br J Cancer. 1999. PMID: 10206289 Free PMC article.

6

Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer.

Hofstra LS, Mourits MJ, de Vries EG, Mulder NH, Willemse PH. Hofstra LS, et al. Among authors: mourits mj. Anticancer Res. 1999 Jul-Aug;19(4C):3627-30. Anticancer Res. 1999. PMID: 10629663 Clinical Trial.

7

Tamoxifen treatment and gynecologic side effects: a review.

Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Mourits MJ, et al. Obstet Gynecol. 2001 May;97(5 Pt 2):855-66. doi: 10.1016/s0029-7844(00)01196-0. Obstet Gynecol. 2001. PMID: 11336777 Review.

8

[The effects of tamoxifen on the female genital tract].

Mourits MJ, van der Zee AG, Willemse PH, Hollema H, de Vries EG. Mourits MJ, et al. Ned Tijdschr Geneeskd. 2003 Nov 22;147(47):2315-20. Ned Tijdschr Geneeskd. 2003. PMID: 14669536 Review. Dutch.

9

Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.

Buijs C, Willemse PH, Tinga DJ, Hollema H, de Vries EG, Mourits MJ. Buijs C, et al. Among authors: mourits mj. J Clin Oncol. 2004 Jun 15;22(12):2505-7. doi: 10.1200/JCO.2004.07.123. J Clin Oncol. 2004. PMID: 15197214 No abstract available.

10

A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer.

Bos AM, De Vos FY, de Vries EG, Beijnen JH, Rosing H, Mourits MJ, van der Zee AG, Gietema JA, Willemse PH. Bos AM, et al. Among authors: mourits mj. Eur J Cancer. 2005 Mar;41(4):539-48. doi: 10.1016/j.ejca.2004.12.003. Epub 2005 Jan 11. Eur J Cancer. 2005. PMID: 15737558 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters